UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil.
about
Absolute quantification of UGT1A1 in various tissues and cell lines using isotope label-free UPLC-MS/MS method determines its turnover number and correlates with its glucuronidation activities.Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis.Clinical significance of UGT1A1 gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancerComputational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines.Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy.Severe irinotecan-induced toxicity in a patient with UGT1A1 28 and UGT1A1 6 polymorphisms.A rare case of primary choriocarcinoma in the sigmoid colonUGT1A1 polymorphisms in cancer: impact on irinotecan treatment.Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.Gastric cancer pharmacogenetics: progress or old tripe?Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.Role of Preemptive Genotyping in Preventing Serious Adverse Drug Events in South Korean Patients.UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis.Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapyIntegrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer.Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan-induced toxicity in patients with cancer.Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.The association of UGT1A1*6 and UGT1A1*28 with irinotecan-induced neutropenia in Asians: a meta-analysis.
P2860
Q33567176-4EC65C8A-6F7D-49D8-8D8F-A5385948A130Q33823686-33E51DD9-0214-4CF3-B52D-DA7B38C7AC6DQ34274096-13BA8331-B2BB-4F6E-9152-746D4BB29806Q35993392-B29CAE54-0111-41F0-B098-351D738460D6Q36815039-7BCFD0A3-68D8-4069-B974-97FD6506C9DDQ36975047-9132652C-56C6-4B4D-BBAC-FB00698FCA41Q37241641-A2498A24-32DA-4BB2-9EA3-B1A05384E47AQ37682812-BF8FB0BC-0E3F-4876-BB05-B998CCCEB806Q37726433-D6389C33-257C-42D2-B496-827D81882D7BQ38120288-A1EBBAE0-8722-40CA-BF5E-D1ADC9B25787Q38922471-726C4048-D35F-4E7B-8832-150ACAC948B7Q38957310-3D0F945C-9FE6-43F0-86F6-CE8AC16B1224Q39353625-EEE6BE72-2959-4909-9CFF-756B5D6BF8FEQ40494116-2F05733F-8FF1-48FF-9D95-CA5D7FE059AAQ41608501-0A609EE6-25E4-4988-B219-0E965B6185D9Q44351944-895B93CE-4911-41CA-907E-401D7C700C4CQ48298629-DF225A20-DD1D-475E-BC37-A367072E07F7Q52362144-B43FE990-66E2-4797-BFC2-372BCC4990D8Q54486022-77D19250-30CB-4305-B9BD-2C4CF32FF73D
P2860
UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil.
@ast
UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil.
@en
type
label
UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil.
@ast
UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil.
@en
prefLabel
UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil.
@ast
UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil.
@en
P2093
P2860
P356
P1476
UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil.
@en
P2093
Jian-Ming Xu
Jin-Wan Wang
Shun-Chang Jiao
Ze-Yuan Liu
P2860
P304
P356
10.3748/WJG.V18.I45.6635
P407
P577
2012-12-01T00:00:00Z